PubMed COVID-19 Clinical Care

The search for alternative naturally occurring antimicrobial agents will always continue, especially when emerging diseases like COVID-19 provide an urgency to identify and develop safe and effective ways to prevent or treat these infections. The

We developed a 4-parameter clinical assay using Electric Field--- Induced Release and Measurement (EFIRM) technology to simultaneously assess SARS-CoV-2 RNA (vRNA), nucleocapsid antigen, host binding (BAb) and neutralizing antibody (NAb) levels from

The coronavirus disease (COVID-19) pandemic has brought into sharp relief the threat posed by coronaviruses and laid the foundation for a fundamental analysis of this viral family, as well as a search for effective anti-COVID drugs. Work is underway

CONCLUSIONS: TheraPPP will evaluate the effectiveness and implementation of an HRF and ARDS care pathway.

CONCLUSIONS: Employee emotional and psychological well-being are associated with SRIRA. Future work should explore causal relationships between these constructs.

CONCLUSIONS: TheraPPP will evaluate the effectiveness and implementation of an HRF and ARDS care pathway.

CONCLUSIONS: TheraPPP will evaluate the effectiveness and implementation of an HRF and ARDS care pathway.

Bronchiolitis is a common cause of hospitalization in infants. The long-lasting impact of hygiene and social behavior changes during the pandemic on this disease is debated. We investigated the prevalence of hospitalized cases, clinical severity, and

CONCLUSIONS: The expected benefit of receiving the primary series of mRNA vaccines outweighed the risk among children ages 6 months to 4 years regardless of sex, presence of underlying medical conditions, presence of infection-induced immunity or

Obstructive sleep apnea is a well-known risk factor regarding the severity of COVID-19 infection. However, to date, relatively little research performed on the prevalence of obstructive sleep apnea in COVID-19 survivors. The purpose of this study was